Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Caprion Biosciences

Caprion Biosciences
2000 FOUNDED
PRIVATE STATUS
101-200 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
5 FINANCING ROUNDS
5 INVESTMENTS
Description

Provider of proteomics and immune monitoring services for the pharmaceutical and biotechnology industry. The company operates two proprietary immune monitoring platforms that offers proprietary multiparametric flow cytometry services for functional analyses of innate and adaptive immune responses and its proteomics business unit, as well as gel-free, label-free mass spectrometry (MS) for comprehensive, quantitative and robust comparative measurement of proteins across large sets of biological samples for the discovery and validation of protein biomarkers.

Website
Formerly Known As
Caprion Proteomics, Caprion Proteomics GP
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 141 President Kennedy Avenue
  • Suite SB-5658
  • Montreal, Quebec H2X 3Y7
  • Canada

+1 (514) 000-0000

Caprion Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Caprion Biosciences‘s full profile, request access.

Request full access to PitchBook

Caprion Biosciences Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AyoxxA Biosystems Venture Capital-Backed Cologne, Germany 00 0000 000000000000 0000
000000 00000000 Angel-Backed Durham, NC 00 000.00 0000000000 000.00
0000 000000000 000 Corporation Danvers, MA
0000000 Corporation Austin, TX 0000 000.00 00000000 000.00
000000000000 00000 Formerly VC-backed Boston, MA 00 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Caprion Biosciences Investments (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 31-Jul-2019 0000000000 Laboratory Services (Healthcare) 000000 0000000
0000000000 30-Apr-2019 0000000000 Outcome Management (Healthcare) 000000 0000000
0000000 000 21-Aug-2018 0000000000 Drug Discovery 000000 0000000
000000 0000000000 13-Sep-2016 0000000000 Buildings and Property 000000 0000000
National Immune Monitoring Laboratory (Certain Assets) 01-Jan-2011 Buyout/LBO Biotechnology
To view this company’s complete investment and acquisition history, request access »

Caprion Biosciences Subsidiaries (2)

Company Name Industry Location Founded
Primity Bio Drug Discovery Fremont, CA 2010
0000000000 Outcome Management (Healthcare) Carlsbad, CA 0000
To view this company’s complete subsidiary history, request access »

Caprion Biosciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Caprion Biosciences‘s full profile, request access.

Request full access to PitchBook

Caprion Biosciences Executive Team (9)

Name Title Board
Seat
Contact
Info
Martin LeBlanc Board Member, President, Chief Executive Officer and Co-Founder
Normand Rivard Senior Vice President & Chief Financial Officer
Lorella Di Donato Ph.D Chief Operating Officer & Senior Vice President
Carol Berry Senior Vice President & Chief Business Officer
Patrick Tremblay Ph.D Senior Vice President & Corporate Development Officer

4 Former Executives

You’re viewing 5 of 9 executives. Get the full list »